首页> 外文期刊>Acta Pharmacologica Sinica >R-dl-Verapamil downmodulates multidrug resistance of KBv200 cells to vincristine and doxorubicin
【24h】

R-dl-Verapamil downmodulates multidrug resistance of KBv200 cells to vincristine and doxorubicin

机译:R-dl-维拉帕米可下调KBv200细胞对长春新碱和阿霉素的多药耐药性

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To study the attenuation of multidrug resistance (MDR) by R-dl-verapamil (R-Ver) and the acute animal toxicity of R-Ver, and to compare these results of R-Ver with the resutls of dl-verapamil (Ver). METHODS: Cytotoxicity was determined by Tetraxolium (MTT) assay. Cellular accumulation of Doxorubicin (Dox) was measured by fluorescence Spectrophotometry. Acute animal toxicity was tested By ip drug administration in BALB/c mice. CONCLUSION: R-Ver downmodulated the MDR to VCR And Dox at 1.25 μmol·L~-1, and this effect on VCR Can be realized with drug exposure duration of 24 h.
机译:目的:研究R-dl-维拉帕米(R-Ver)对多药耐药性(MDR)的减弱和R-Ver的急性动物毒性,并将R-Ver的这些结果与dl-维拉帕米的结果进行比较(版本)。方法:采用四氧噻唑(MTT)法测定细胞毒性。通过荧光分光光度法测量阿霉素(Dox)的细胞积累。通过在BALB / c小鼠中腹膜内给药来测试急性动物毒性。结论:R-Ver以1.25μmol·L〜-1将MDR下调为VCR和Dox,药物暴露时间为24 h即可实现对VCR的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号